NAPSA Antikörper (AA 20-158)
(1 reference)-
- Target Alle NAPSA Antikörper anzeigen
- NAPSA (Napsin A Aspartic Peptidase (NAPSA))
-
Bindungsspezifität
- AA 20-158
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser NAPSA Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
- Verwendungszweck
- NAPSA Antibody
- Aufreinigung
- Purified antibody
- Immunogen
- Purified recombinant fragment of human NAPSA (AA: 20-158) expressed in E. Coli.
- Klon
- 10C4B8
- Isotyp
- IgG1
-
anti-Napsin A Aspartic Peptidase (NAPSA) (AA 189-299) antibody
NAPSA Reaktivität: Human WB, IHC, IF, FACS, StM Wirt: Maus Monoclonal NAPSA-1238 unconjugated
anti-Napsin A Aspartic Peptidase (NAPSA) (AA 25-250) antibodyNAPSA Reaktivität: Human WB, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Napsin A Aspartic Peptidase (NAPSA) (AA 64-420) antibodyNAPSA Reaktivität: Human WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Napsin A Aspartic Peptidase (NAPSA) antibodyNAPSA Reaktivität: Human, Maus WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Napsin A Aspartic Peptidase (NAPSA) (AA 189-299) antibodyNAPSA Reaktivität: Human IHC, StM Wirt: Maus Monoclonal NAPSA-3309 unconjugated
anti-Napsin A Aspartic Peptidase (NAPSA) (AA 189-299) antibodyNAPSA Reaktivität: Human IHC Wirt: Kaninchen Monoclonal MSVA-112R unconjugated Recombinant Antibody
anti-Napsin A Aspartic Peptidase (NAPSA) (AA 368-397), (C-Term) antibodyNAPSA Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal RB33879 unconjugated
anti-Napsin A Aspartic Peptidase (NAPSA) (AA 189-299) antibodyNAPSA Reaktivität: Human IHC, StM Wirt: Maus Monoclonal rNAPSA-1239 unconjugated Recombinant Antibody
anti-Napsin A Aspartic Peptidase (NAPSA) (AA 189-299) antibodyNAPSA Reaktivität: Human IHC, StM Wirt: Kaninchen Monoclonal NAPSA-1865R unconjugated Recombinant Antibody
anti-Napsin A Aspartic Peptidase (NAPSA) (AA 189-299) antibodyNAPSA Reaktivität: Human WB, IHC, IF, FACS, StM Wirt: Maus Monoclonal NAPSA-1238-NAPSA-1239 unconjugated
-
- Applikationshinweise
- ELISA: 1/10000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Purified antibody in PBS with 0.05 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
-
-
: "Comparison of the expression levels of napsin A, thyroid transcription factor-1, and p63 in nonsmall cell lung cancer using cytocentrifuged bronchial brushings." in: Cancer cytopathology, Vol. 119, Issue 5, pp. 335-45, (2011) (PubMed).
-
: "Comparison of the expression levels of napsin A, thyroid transcription factor-1, and p63 in nonsmall cell lung cancer using cytocentrifuged bronchial brushings." in: Cancer cytopathology, Vol. 119, Issue 5, pp. 335-45, (2011) (PubMed).
-
- Target
- NAPSA (Napsin A Aspartic Peptidase (NAPSA))
- Andere Bezeichnung
- NAPSA (NAPSA Produkte)
- Hintergrund
-
Description: The activation peptides of aspartic proteinases plays role as inhibitors of the active site. These peptide segments, or pro-parts, are deemed important for correct folding, targeting, and control of the activation of aspartic proteinase zymogens. The pronapsin A gene is expressed predominantly in lung and kidney. Its translation product is predicted to be a fully functional, glycosylated aspartic proteinase precursor containing an RGD motif and an additional 18 residues at its C-terminus.
Aliases: KAP, Kdap, NAP1, NAPA, SNAPA
- Molekulargewicht
- 45.4kDa
- Gen-ID
- 9476
- HGNC
- 9476
- UniProt
- O96009
- Pathways
- Tube Formation, Asymmetric Protein Localization, Embryonic Body Morphogenesis
-
